المؤلفون: Sun LY; Second Department of Oncology, Guangdong Second Provincial General Hospital, Guangzhou, Guangdong, China., Cen WJ; Department of Molecular Diagnostics, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China., Zeng XX; Second Department of Oncology, Guangdong Second Provincial General Hospital, Guangzhou, Guangdong, China., Zhong YY; Department of Postdoctoral Workstation, HuaBo Biological Pharmaceutic Research Institute, Guangzhou, Guangdong, China., Deng L; Department of Molecular Diagnostics, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China., Yang JJ; Department of Oncology, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, Guangdong, China., Li M; Medical Research Center, Guangdong Second Provincial General Hospital, Guangzhou, Guangdong, China., Wang F; Department of Molecular Diagnostics, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.

المصدر: The American surgeon [Am Surg] 2024 Jun; Vol. 90 (6), pp. 1240-1249. Date of Electronic Publication: 2024 Jan 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: SAGE Publications in association with Southeastern Surgical Congress Country of Publication: United States NLM ID: 0370522 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1555-9823 (Electronic) Linking ISSN: 00031348 NLM ISO Abbreviation: Am Surg Subsets: MEDLINE

مواضيع طبية MeSH: alpha-Fetoproteins*/metabolism , alpha-Fetoproteins*/analysis , Carcinoma, Hepatocellular*/surgery , Carcinoma, Hepatocellular*/mortality , Carcinoma, Hepatocellular*/blood , Carcinoma, Hepatocellular*/pathology , Liver Neoplasms*/surgery , Liver Neoplasms*/mortality , Liver Neoplasms*/blood , Liver Neoplasms*/pathology , Liver Neoplasms*/metabolism , Hepatectomy*, Humans ; Male ; Female ; Retrospective Studies ; Middle Aged ; Prognosis ; Aged ; Adult ; Biomarkers, Tumor/blood ; Biomarkers, Tumor/metabolism ; Disease-Free Survival ; Predictive Value of Tests ; Immunohistochemistry

المؤلفون: Sun T; School of Opto-electronic and Communication Engineering, Xiamen University of Technology, Xiamen, Fujian, 361024, China., Lin Y; MOE Key Laboratory of Opto Electronic Science and Technology for Medicine and Fujian Provincial Key Laboratory for Photonics Technology, Fujian Normal University, Fuzhou, Fujian, 350007, China., Yu Y; College of Integrative Medicine, Laboratory of Pathophysiology, Key Laboratory of Integrative Medicine on Chronic Diseases (Fujian Province University), Synthesized Laboratory of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, 350122, China. Electronic address: yuyunsatan@163.com., Gao S; Key Laboratory of Optoelectronic Devices and Systems of Guangdong Province and the Ministry of Education, College of Physics and Optoelectronic Engineering, Shenzhen University, Shenzhen, 518060, China., Gao X; School of Opto-electronic and Communication Engineering, Xiamen University of Technology, Xiamen, Fujian, 361024, China., Zhang H; School of Opto-electronic and Communication Engineering, Xiamen University of Technology, Xiamen, Fujian, 361024, China., Lin K; Department of Hepatobiliary Surgery, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350025, China., Lin J; School of Opto-electronic and Communication Engineering, Xiamen University of Technology, Xiamen, Fujian, 361024, China. Electronic address: jqlin@t.xmut.edu.cn.

المصدر: Analytica chimica acta [Anal Chim Acta] 2024 May 22; Vol. 1304, pp. 342518. Date of Electronic Publication: 2024 Mar 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0370534 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4324 (Electronic) Linking ISSN: 00032670 NLM ISO Abbreviation: Anal Chim Acta Subsets: MEDLINE

مواضيع طبية MeSH: Blood Proteins* , Liver Neoplasms*/diagnosis, Humans ; Discriminant Analysis ; Biomarkers ; Spectrum Analysis, Raman/methods ; Principal Component Analysis

المؤلفون: Guo JC; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan., Hsu CL; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan., Hsieh MS; Department of Pathology, National Taiwan University Cancer Center, Taipei, Taiwan., Lin CC; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan., Huang TC; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan., Kuo HY; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan., Shao YY; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan., Hsu CH; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan.; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan.

المصدر: Thoracic cancer [Thorac Cancer] 2023 Aug; Vol. 14 (22), pp. 2216-2221. Date of Electronic Publication: 2023 Jun 20.

نوع المنشور: Case Reports; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley Publishing Asia Pty Ltd Country of Publication: Singapore NLM ID: 101531441 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1759-7714 (Electronic) Linking ISSN: 17597706 NLM ISO Abbreviation: Thorac Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Esophageal Neoplasms*/pathology , Esophageal Squamous Cell Carcinoma*/pathology , Liver Neoplasms*, Humans ; Immune Checkpoint Inhibitors/therapeutic use ; Immunohistochemistry

المؤلفون: Shao YY; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan. yuyunshao@gmail.com.; Department of Oncology, National Taiwan University Hospital, 7, Chung-Shan S. Rd., Taipei City, 10002, Taiwan. yuyunshao@gmail.com.; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan. yuyunshao@gmail.com.

المصدر: Hepatology international [Hepatol Int] 2023 Apr; Vol. 17 (2), pp. 279-280. Date of Electronic Publication: 2023 Mar 31.

نوع المنشور: Editorial; Comment

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 101304009 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1936-0541 (Electronic) Linking ISSN: 19360533 NLM ISO Abbreviation: Hepatol Int Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Hepatocellular*/diagnosis , Carcinoma, Hepatocellular*/pathology , Liver Neoplasms*/diagnosis , Liver Neoplasms*/pathology, Humans ; Prognosis ; Biomarkers, Tumor

المؤلفون: Chen BB; Department of Medical Imaging, National Taiwan University Hospital, Taipei City, Taiwan.; Department of Radiology, College of Medicine, National Taiwan University, Taipei City, Taiwan., Liang PC; Department of Medical Imaging, National Taiwan University Hospital, Taipei City, Taiwan.; Department of Radiology, College of Medicine, National Taiwan University, Taipei City, Taiwan.; Department of Medical Imaging, National Taiwan University Hospital Hsin-Chu Branch, Hsin-Chu City, 300, Taiwan., Shih TT; Department of Medical Imaging, National Taiwan University Hospital, Taipei City, Taiwan.; Department of Radiology, College of Medicine, National Taiwan University, Taipei City, Taiwan., Liu TH; Department of Oncology, National Taiwan University Hospital, No 7, Chung-Shan South Rd, Taipei City, 100, Taiwan.; Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei City, Taiwan.; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan., Shen YC; Department of Oncology, National Taiwan University Hospital, No 7, Chung-Shan South Rd, Taipei City, 100, Taiwan.; Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei City, Taiwan.; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan., Lu LC; Department of Oncology, National Taiwan University Hospital, No 7, Chung-Shan South Rd, Taipei City, 100, Taiwan.; Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei City, Taiwan.; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan., Lin ZZ; Department of Oncology, National Taiwan University Hospital, No 7, Chung-Shan South Rd, Taipei City, 100, Taiwan.; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan., Hsu C; Department of Oncology, National Taiwan University Hospital, No 7, Chung-Shan South Rd, Taipei City, 100, Taiwan.; Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei City, Taiwan.; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan., Hsu CH; Department of Oncology, National Taiwan University Hospital, No 7, Chung-Shan South Rd, Taipei City, 100, Taiwan.; Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei City, Taiwan.; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan., Cheng AL; Department of Oncology, National Taiwan University Hospital, No 7, Chung-Shan South Rd, Taipei City, 100, Taiwan.; Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei City, Taiwan.; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan.; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Shao YY; Department of Oncology, National Taiwan University Hospital, No 7, Chung-Shan South Rd, Taipei City, 100, Taiwan. yuyunshao@gmail.com.; Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei City, Taiwan. yuyunshao@gmail.com.; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan. yuyunshao@gmail.com.

المصدر: European radiology [Eur Radiol] 2023 Jan; Vol. 33 (1), pp. 512-522. Date of Electronic Publication: 2022 Jul 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer International Country of Publication: Germany NLM ID: 9114774 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1084 (Electronic) Linking ISSN: 09387994 NLM ISO Abbreviation: Eur Radiol Subsets: MEDLINE

مواضيع طبية MeSH: Sarcopenia*/complications , Sarcopenia*/diagnostic imaging , Sarcopenia*/epidemiology , Carcinoma, Hepatocellular*/complications , Carcinoma, Hepatocellular*/therapy , Liver Neoplasms*/complications , Liver Neoplasms*/therapy, Humans ; Retrospective Studies ; Prognosis ; Muscle, Skeletal/pathology ; Obesity/complications ; Obesity/epidemiology ; Obesity/pathology ; Immunotherapy

المؤلفون: Shao YY; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan. Electronic address: yuyunshao@gmail.com., Feng YH; Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan., Yen CJ; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Yang TS; Department of Hematology-Oncology, Linkou Chang Gung Memorial Hospital, College of Medicine, Chang Gung University, Tao-Yuan, Taiwan., Shen YC; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan., Chao Y; Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan., Chen JS; Department of Hematology-Oncology, Linkou Chang Gung Memorial Hospital, College of Medicine, Chang Gung University, Tao-Yuan, Taiwan., Su CY; Medical Division, Roche Products Ltd, Taipei, Taiwan., Chen WJ; Medical Division, Roche Products Ltd, Taipei, Taiwan., Hsiang HL; Medical Division, Roche Products Ltd, Taipei, Taiwan., Hsu CH; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan.

المصدر: Journal of the Formosan Medical Association = Taiwan yi zhi [J Formos Med Assoc] 2022 Dec; Vol. 121 (12), pp. 2430-2437. Date of Electronic Publication: 2022 Sep 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Formosan Medical Association, Elsevier Country of Publication: Singapore NLM ID: 9214933 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 0929-6646 (Print) Linking ISSN: 09296646 NLM ISO Abbreviation: J Formos Med Assoc Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Carcinoma, Hepatocellular*/drug therapy , Liver Neoplasms*/drug therapy, Humans ; Middle Aged ; Antibodies, Monoclonal, Humanized ; Bevacizumab

المؤلفون: Chen CT; Department of Oncology, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan, ROC.; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan, ROC., Feng YH; Division of Hematology and Oncology, Department of Internal Medicine, Chi-Mei Medical Center, Tainan, Taiwan, ROC., Yen CJ; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan, ROC., Chen SC; Division of Medical Oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan, ROC., Lin YT; Division of Hematology and Oncology, Department of Internal Medicine, Chi-Mei Medical Center, Tainan, Taiwan, ROC., Lu LC; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan, ROC.; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan, ROC.; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan, ROC., Hsu CH; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan, ROC.; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan, ROC.; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan, ROC., Cheng AL; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan, ROC.; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan, ROC.; Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan, ROC.; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan, ROC., Shao YY; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan, ROC. yuyunshao@gmail.com.; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan, ROC. yuyunshao@gmail.com.; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan, ROC. yuyunshao@gmail.com.

المصدر: Hepatology international [Hepatol Int] 2022 Oct; Vol. 16 (5), pp. 1199-1207. Date of Electronic Publication: 2022 Aug 20.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 101304009 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1936-0541 (Electronic) Linking ISSN: 19360533 NLM ISO Abbreviation: Hepatol Int Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Hepatocellular*/pathology , Liver Neoplasms*/pathology, Antibodies, Monoclonal, Humanized ; Bevacizumab/therapeutic use ; Humans ; Prognosis ; Sorafenib

المؤلفون: Chen CT; Department of Oncology, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan, R.O.C.; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan, R.O.C., Hsu CH; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan, R.O.C.; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan, R.O.C., Cheng AL; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan, R.O.C.; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan, R.O.C.; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan, R.O.C.; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan, R.O.C., Shao YY; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan, R.O.C.; yuyunshao@gmail.com.; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan, R.O.C.

المصدر: Anticancer research [Anticancer Res] 2022 Sep; Vol. 42 (9), pp. 4461-4470.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents*/therapeutic use , Carcinoma, Hepatocellular*/pathology , Chemoembolization, Therapeutic*/methods , Liver Neoplasms*/pathology, Female ; Humans ; Male ; Middle Aged ; Niacinamide/therapeutic use ; Phenylurea Compounds/therapeutic use ; Retrospective Studies ; Sorafenib/therapeutic use ; Treatment Outcome

المؤلفون: Shao YY; Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei City, 10055, Taiwan.; Department of Oncology, National Taiwan University Hospital, Taipei City, 10048, Taiwan.; National Taiwan University Cancer Center, Taipei City, 10672, Taiwan., Chen PS; Department of Medical Laboratory Science and Biotechnology, National Cheng Kung University, Tainan City, 70101, Taiwan., Lin LI; Graduate Institute of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei City, 10048, Taiwan., Lee BS; Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei City, 10055, Taiwan., Ling A; Columbia University Vagelos College of Physicians and Surgeons, New York, NY, 10032, USA., Cheng AL; Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei City, 10055, Taiwan.; Department of Oncology, National Taiwan University Hospital, Taipei City, 10048, Taiwan.; National Taiwan University Cancer Center, Taipei City, 10672, Taiwan.; Department of Internal Medicine, National Taiwan University Hospital, Taipei City, 10048, Taiwan., Hsu C; Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei City, 10055, Taiwan.; Department of Oncology, National Taiwan University Hospital, Taipei City, 10048, Taiwan.; National Taiwan University Cancer Center, Taipei City, 10672, Taiwan., Ou DL; Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei City, 10055, Taiwan. dlou@ntu.edu.tw.; YongLin Institute of Health, National Taiwan University, Taipei City, 10672, Taiwan. dlou@ntu.edu.tw.

المصدر: British journal of cancer [Br J Cancer] 2022 Jun; Vol. 126 (12), pp. 1806-1814. Date of Electronic Publication: 2022 Mar 02.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Hepatocellular*/drug therapy , Carcinoma, Hepatocellular*/genetics , Carcinoma, Hepatocellular*/metabolism , Carcinoma, Hepatocellular*/pathology , Liver Neoplasms*/drug therapy , Liver Neoplasms*/genetics , Liver Neoplasms*/metabolism , Liver Neoplasms*/pathology , MicroRNAs*/genetics , MicroRNAs*/metabolism , Sorafenib*/pharmacology, Apoptosis ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Drug Resistance, Neoplasm ; Humans

المؤلفون: Chen SC; Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.; Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.; Division of Medical Oncology, Center for Immuno-oncology, Department of Oncology, Taipei Veterans General Hospital, No. 201, Sec. 2, Shipai Road, Taiwan, 11217, Taipei, Taiwan., Huang YH; Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.; Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.; Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan., Chen MH; Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.; Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.; Division of Medical Oncology, Center for Immuno-oncology, Department of Oncology, Taipei Veterans General Hospital, No. 201, Sec. 2, Shipai Road, Taiwan, 11217, Taipei, Taiwan., Hung YP; Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.; Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.; Division of Medical Oncology, Center for Immuno-oncology, Department of Oncology, Taipei Veterans General Hospital, No. 201, Sec. 2, Shipai Road, Taiwan, 11217, Taipei, Taiwan., Lee RC; Department of Radiology, Taipei Veterans General Hospital, Taipei, Taiwan., Shao YY; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan., Chao Y; Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan. ychao@vghtpe.gov.tw.; Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan. ychao@vghtpe.gov.tw.; Division of Medical Oncology, Center for Immuno-oncology, Department of Oncology, Taipei Veterans General Hospital, No. 201, Sec. 2, Shipai Road, Taiwan, 11217, Taipei, Taiwan. ychao@vghtpe.gov.tw.

المصدر: BMC cancer [BMC Cancer] 2022 Jan 11; Vol. 22 (1), pp. 55. Date of Electronic Publication: 2022 Jan 11.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Hepatocellular*/drug therapy , Carcinoma, Hepatocellular*/mortality , Carcinoma, Hepatocellular*/pathology , Liver Neoplasms*/drug therapy , Liver Neoplasms*/mortality , Liver Neoplasms*/pathology, Antineoplastic Agents/*therapeutic use , Immune Checkpoint Inhibitors/*therapeutic use , Sorafenib/*therapeutic use, Aged ; Aged, 80 and over ; Drug Therapy, Combination ; Female ; Humans ; Male ; Middle Aged ; Programmed Cell Death 1 Receptor/antagonists & inhibitors ; Propensity Score ; Retrospective Studies